Dr. Anasufiza Binti Habib

BSc in Medical Science (University of St Andrews, UK), MBChB (University of Manchester, UK), Master in Pathology (Chemical Pathology) (UKM, Malaysia)

Google Scholar | ORCID | ResearchGate

Telephone: +603- 2261 2771

Email: anasufiza@moh.gov.my

• To improve public health by providing accurate, rapid, and high-standard biomedical research and diagnostic services to support clinical disease management.

• To support national health priorities by providing specialised diagnostic reference services for Inborn Errors of Metabolism (IEM), genetic, endocrine, and non-communicable diseases across hospitals in Malaysia.

• To develop the nation’s capacity in advanced diagnostic technology and laboratories through technology transfer, specialist training, and innovation.

• To strengthen translational research through specialised laboratory services using high-end omics platforms.

• To enhance awareness and professional standards through technical training and collaboration with local and international health institutions.

• To provide specialised diagnostic services and serve as a reference laboratory for Inborn Errors of Metabolism (IEM), genetic, endocrine, and non-communicable diseases across hospitals in Malaysia.

• To offer advanced laboratory support and analytical services, including genetic biochemistry, molecular, genomic, proteomic testing, and high-tech diagnostics.

• To support basic and translational research by providing critical diagnostic data for advanced research and development (R&D), as well as new laboratory methods and biomarkers.

• To develop capacity and provide technical training for researchers, laboratory officers, and health professionals to ensure sustained diagnostic expertise.

• To provide technical and scientific consultation services to ministries, government agencies, health institutions, and industry in diagnostics and disease management.

• To enhance digital health innovation by managing specimens and reports to improve efficiency, traceability, and service quality in diagnostics and research, utilised by IMR and clients from government and private laboratories/hospitals across Malaysia and abroad.

The Biochemistry Unit serves as a reference center for specialised diagnostic services, offering comprehensive biochemical genetic testing for Inborn Errors of Metabolism (IEM), conducting biomedical research, and developing diagnostic methods. It also provides training in biochemical genetics for local and international researchers and students, and offers consultancy services to hospitals, universities, and other organisations.

• Specialised diagnostic services and biochemical genetic testing for Inborn Errors of Metabolism (IEM) and rare genetic disorders.
• Research in biochemical genetics, particularly IEM
• Testing methods to determine incidence and diagnostic indicators.
• Training programs in biochemical genetics.
• Consultancy services in biochemical genetics.

The Endocrine Unit provides specialised diagnostic services, conducts research on new biomarkers, offers training for local and international researchers and students, and delivers consultancy services in endocrinology and non-communicable diseases.

• Specialised diagnostic services and comprehensive testing in endocrinology and non-communicable diseases.
• Biomedical research on new biomarkers in inherited endocrine metabolic disorders and other non-communicable diseases.
• Testing methods to determine incidence and diagnostic indicators are developed.
• Training programs in endocrinology and non-communicable diseases.
• Consultancy services in endocrine metabolic disorders.

The Molecular Diagnostics Unit provides specialised genetic testing for IEM and rare genetic diseases, conducts research, develops diagnostic methods, and offers training and consultancy services to local and international institutions.

• Specialised diagnostic services and comprehensive molecular genetics testing for Inborn Errors of Metabolism (IEM) and rare genetic diseases.
• Biomedical research in inherited metabolic disorders, mitochondrial diseases, genetic syndromes, neurogenetic disorders, and other genetic conditions.
• Testing methods to determine incidence and diagnostic indicators are developed.
• Training programs in molecular genetics.
• Consultancy services in molecular genetics.

The Special Protein Unit provides specialised protein diagnostic services, conducts advanced biomedical R&D including new laboratory methods and biomarker discovery, offers training for local and international researchers and students, and delivers consultancy services in specialised protein diagnostics.

• Specialised diagnostic services and testing for Inborn Errors of Metabolism (IEM) and non-communicable diseases.
• Biomedical research on new biomarkers in inherited protein metabolic disorders and other non-communicable diseases.
• Testing methods to determine incidence and diagnostic indicators.
• Training programs in protein metabolic disorders.
• Consultancy services in protein metabolic disorders.

The Specimen Management Unit (UPS) manages the receipt, processing, and distribution of diagnostic and research specimens, coordinates testing services and results, and drives digital health innovation through digitalised specimen management and reporting.

• The receiving, processing, and distribution of diagnostic and research specimens.
• Diagnostic and research testing services and laboratory results coordination.
• Digitalisation of specimen management and full digital reporting.